RBC Capital Maintains Outperform on Tenet Healthcare, Raises Price Target to $87
Portfolio Pulse from richadhand@benzinga.com
RBC Capital analyst Ben Hendrix maintains an Outperform rating on Tenet Healthcare (NYSE:THC) and raises the price target from $84 to $87.
August 01, 2023 | 2:44 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital maintains an Outperform rating on Tenet Healthcare and raises the price target from $84 to $87. This could potentially lead to a positive impact on the stock's price.
The raised price target by RBC Capital indicates a positive outlook for Tenet Healthcare. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100